M. Angélico

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

Vlad Ratziu, Stephen A. Harrison, Sven Francque et al. · Gastroenterology · 2016 · 993 citations · Full text

Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial

Paolo Caraceni, Oliviero Riggio, Paolo Angeli et al. · The Lancet · 2018 · 499 citations · Full text

Hepatology, Decompensated Cirrhosis, Liver Physiology +6

Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial

Vincenzo Mazzaferro, Davide Citterio, Sherrie Bhoori et al. · The Lancet Oncology · 2020 · 314 citations · Full text

Surgical Oncology, Transplantation, Hepatology +11

Bile acid-induced liver toxicity: Relation to the hydrophobic-hydrophilic balance of bile acids

A.F. Attili, M. Angélico, Alfredo Cantàfora et al. · Medical Hypotheses · 1986 · 275 citations

Bile Acids, Hydrophobic-hydrophilic Balance, Hepatology +12